Back
KraneShares Asia Pacific HiUSD ETF Vs. NovoCure Industry Stock Comparison
Sell
41
KHYB
KraneShares Asia Pacific HiUSD ETF
Last Price:
24.89
Seasonality Move:
-2.66%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Sell
41
KraneShares Asia Pacific HiUSD ETF (KHYB)
is a Sell
Is KraneShares Asia Pacific HiUSD ETF a Buy, Sell or Hold?
- The current KraneShares Asia Pacific HiUSD ETF [KHYB] share price is $24.89. The Score for KHYB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- KHYB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KHYB Stock Price Chart
What is KraneShares Asia Pacific HiUSD ETF's stock price today?
-
The KraneShares Asia Pacific HiUSD ETF share price today is $24.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KHYB is experiencing selling pressure, which indicates risk of future bearish movement.
KHYB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 46.73 | Sell |
| Chaikin Money Flow: | -2342 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.82 - 25.04) | Sell |
| Bollinger Bands (100): | (24.84 - 25.14) | Sell |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.78 | Buy |
| Relative Strength Index (14 RSI): | 75.34 | Buy |
| Chaikin Money Flow: | 1118573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.36 - 28.56) | Buy |
| Bollinger Bands (100): | (14.7 - 22.78) | Buy |
KHYB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.85 | Buy |
| 20-day SMA: | 24.89 | Buy |
| 50-day SMA: | 25.03 | Sell |
| 200-day SMA: | 24.85 | Buy |
| 8-day EMA: | 24.87 | Buy |
| 20-day EMA: | 24.9 | Sell |
| 50-day EMA: | 24.96 | Sell |
| 200-day EMA: | 24.96 | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.6 | Buy |
| 20-day SMA: | 23.68 | Buy |
| 50-day SMA: | 19.33 | Buy |
| 200-day SMA: | 17.9 | Buy |
| 8-day EMA: | 29.53 | Buy |
| 20-day EMA: | 25.45 | Buy |
| 50-day EMA: | 21.38 | Buy |
| 200-day EMA: | 19.88 | Buy |
KraneShares Asia Pacific HiUSD ETF Earnings Growth & KHYB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
KraneShares Asia Pacific HiUSD ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||